Cargando…

Plasma P-Tau181 for the Discrimination of Alzheimer’s Disease from Other Primary Dementing and/or Movement Disorders

Blood phospho-tau181 may offer a useful biomarker for Alzheimer’s disease. However, the use of either serum or plasma phospho-tau181 and their diagnostic value are currently under intense investigation. In a pilot study, we measured both serum and plasma phospho-tau181 (pT181-Tau) by single molecule...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzartos, John S., Boufidou, Fotini, Stergiou, Christos, Kuhle, Jens, Willemse, Eline, Palaiodimou, Lina, Tsantzali, Ioanna, Sideri, Eleni, Bonakis, Anastasios, Giannopoulos, Sotirios, Voumvourakis, Konstantinos I., Tsivgoulis, Georgios, Tzartos, Socrates J., Kapaki, Elisabeth, Paraskevas, George P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405977/ https://www.ncbi.nlm.nih.gov/pubmed/36008993 http://dx.doi.org/10.3390/biom12081099

Ejemplares similares

Plasma Phospho-Tau-181 as a Diagnostic Aid in Alzheimer’s Disease
por: Tsantzali, Ioanna, et al.
Publicado: (2022)

From Cerebrospinal Fluid Neurochemistry to Clinical Diagnosis of Alzheimer’s Disease in the Era of Anti-Amyloid Treatments. Report of Four Patients
por: Tsantzali, Ioanna, et al.
Publicado: (2021)

The Dynamic Relationship between the Glymphatic System, Aging, Memory, and Sleep
por: Voumvourakis, Konstantinos I., et al.
Publicado: (2023)

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
por: Foska, Aikaterini, et al.
Publicado: (2022)

Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination
por: Pechlivanidou, Maria, et al.
Publicado: (2023)

Sexual dysfunction therapeutic approaches in patients with multiple sclerosis: a systematic review
por: Giannopapas, Vasileios, et al.
Publicado: (2022)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

Diffuse glioma manifesting as normal pressure hydrocephalus: A potential pitfall in diagnosis-a case report
por: Breza, Marianthi, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers and apolipoprotein E genotype in cerebral amyloid angiopathy. A narrative review
por: Theodorou, Aikaterini, et al.
Publicado: (2021)

Recognizing Atypical Presentations of Alzheimer’s Disease: The Importance of CSF Biomarkers in Clinical Practice
por: Paraskevas, George P., et al.
Publicado: (2022)

Blood Biomarkers in Frontotemporal Dementia: Review and Meta-Analysis
por: Ntymenou, Sofia, et al.
Publicado: (2021)

Neuronal and Neuroaxonal Damage Cerebrospinal Fluid Biomarkers in Autoimmune Encephalitis Associated or Not with the Presence of Tumor
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

The Prevalence of Diabetes Mellitus Type II (DMII) in the Multiple Sclerosis Population: A Systematic Review and Meta-Analysis
por: Giannopapas, Vasileios, et al.
Publicado: (2023)

Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy
por: Karagiorgou, Katerina, et al.
Publicado: (2022)

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
por: Tzartos, John S., et al.
Publicado: (2013)

Periodic Limb Movements during Sleep in Acute Stroke: Prevalence, Severity and Impact on Post-Stroke Recovery
por: Plomaritis, Panagiotis, et al.
Publicado: (2023)

Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease: Review and Meta-Analysis
por: Athanasaki, Athanasia, et al.
Publicado: (2022)

Cerebral Amyloid Angiopathy—Related Inflammation: A Single-Center Experience and a Literature Review
por: Theodorou, Aikaterini, et al.
Publicado: (2022)

Delayed Leucoencephalopathy as a Complication after Endovascular Therapy of Intracranial Aneurysms—A Case Series
por: Bakola, Eleni, et al.
Publicado: (2023)

A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis
por: Pafiti, Anna, et al.
Publicado: (2023)

Association of plasma P-tau181 with memory decline in non-demented adults
por: Therriault, Joseph, et al.
Publicado: (2021)

IL-6 Serum Levels in COVID-19 Patients With Vertigo
por: Kitsos, Dimitrios, et al.
Publicado: (2023)

Sleep-Disordered Breathing in Acute Stroke: A Single-Center, Prospective, Longitudinal Study
por: Plomaritis, Panagiotis, et al.
Publicado: (2023)

Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases
por: Kapaki, Elisabeth, et al.
Publicado: (2022)

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
por: Kordas, Gregory, et al.
Publicado: (2014)

Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?
por: Koneczny, Inga, et al.
Publicado: (2021)

Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis
por: Stergiou, Christos, et al.
Publicado: (2023)

Callosal Angle Sub-Score of the Radscale in Patients with Idiopathic Normal Pressure Hydrocephalus Is Associated with Positive Tap Test Response
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2022)

CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal Dementias
por: Constantinides, Vasilios C., et al.
Publicado: (2023)

Alzheimer’s Disease CSF Biomarkers as Possible Indicators of Tap-Test Response in Idiopathic Normal Pressure Hydrocephalus
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2023)

Clinical Characteristics, Neuroimaging Markers, and Outcomes in Patients with Cerebral Amyloid Angiopathy: A Prospective Cohort Study
por: Theodorou, Aikaterini, et al.
Publicado: (2023)

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients
por: Tzartos, John S, et al.
Publicado: (2014)

Stopping “transient ischemic attacks” by antiplatelet withdrawal
por: Palaiodimou, Lina, et al.
Publicado: (2021)

Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy
por: Oberstein, Timo Jan, et al.
Publicado: (2022)

Neurological manifestations of long-COVID syndrome: a narrative review
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2022)

Potential Utility of Neurosonology in Paroxysmal Atrial Fibrillation Detection in Patients with Cryptogenic Stroke
por: Liantinioti, Chrissoula, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers in iNPH: A Narrative Review
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2022)

Structural Insights into the Role of β3 nAChR Subunit in the Activation of Nicotinic Receptors
por: Giastas, Petros, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0uo5fuptvlnp48g4q91lrut39c